Xconomy San Diego

Induced Pluripotent Stem Cells and You

7/21/09
5:30-9:00 p.m.
Tango del Rey, 3567 Del Rey Street, 92109

The San Diego Biotechnology Network has organized a presentation by Dan Shoemaker, the chief technology officer at Fate Therapeutics, and Stephen Chang, the chief scientific officer of Stemgent. They will give a short talk on the industrialization of advanced technology for drug discovery and development based on induced pluripotent stem cells. More information and online registration is here.

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.